Nutrition Thinking® Trial

Summary

The purpose of this study is to scientifically validate Nutrition Thinking®, a novel nutritional approach based on the values and methodologies of Design Thinking.

Conditions

• Overweight

Interventions

BEHAVIORAL

Nutrition Thinking®

In the first session, the nutritionist will carry out the anamnesis through the Empathy Map and assessment of the nutritional status to define the Nutrition Briefing. The steps described by Design Thinking as understanding, observation, and point of view comprise the first phase of this session. The ideation process will proceed from the definition of the Nutrition Challenge. Prototyping is the final stage of the first session, where an initial prototype of the diet will be co-created based on visual thinking tools and the description underlying the creation of diets. Within 24 hours the individual will receive a summary of the material developed by email. The period between sessions will comprise the testing phase and the follow-up sessions the iteration phase where the experience and previous steps are revisited in order to create new insights, anthropometric measurements will be seen as reflections of the experience and not as primary outcomes of the intervention.

BEHAVIORAL

Standard Nutritional Approach

In the first session the nutritionist will carry out the food and nutritional anamnesis and assessment of the nutritional status. From this information, the nutritionist will generate the diagnostic hypothesis and determine the specific nutritional needs. The professional will be responsible for generating the dietary prescription defining the characteristics of the diet that will be delivered printed to the individual after a period of 15 days, in the second session of the protocol. The follow-up session will be based on adherence to the established conduct and monitoring of anthropometric variations.

Sponsors & Collaborators

• Mauricio Kunz

  collaborator UNKNOWN

• Caroline Nespolo de David

  collaborator UNKNOWN

• Renato Gorga Bandeira de Mello

  collaborator UNKNOWN

• Aline Marcadenti de Oliveira

  collaborator UNKNOWN

• Hospital de Clinicas de Porto Alegre

  lead OTHER

Principal Investigators

• Francisca Mosele, PhD · Hospital de Clinicas de Porto Alegre

• Muricio Kunz, PhD · Hospital de Clinicas de Porto Alegre

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Model

PARALLEL

Eligibility

Min Age

25 Years

Max Age

35 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-08-31

Primary Completion

2021-11-30

Completion

2022-02-28

Countries

• Brazil

Study Locations